Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Kutzkey Tim
Relationship:  
City:   San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   35,728,642    

Indirect Shares

  4,162,673      
Direct Value   $434,916,061    

Indirect Value

  $124,372,793      
Total Shares   39,891,315      
Total Value   $559,288,854      


Arcus Biosciences Inc
 $8,213,655 Immune Design Corp.
 $0 Constellation Pharmaceuticals Inc
 $87,862,688 Ngm Biopharmaceuticals Inc
 $27,801,515 Revolution Medicines, Inc.
 $311,038,202 Arcus Biosciences Inc
 $8,213,655 Immune Design Corp.
 $0 Constellation Pharmaceuticals Inc
 $87,862,688 Ngm Biopharmaceuticals Inc
 $27,801,515 Revolution Medicines, Inc.
 $311,038,202
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    10   
    1    

     Stock price went up :

    8   
    0    
     Stock price went down :
    2   
    1    
   
     Gain/Loss Ratio :
   4.0   
   -1.0   
     Percentage Gain/Loss :
   42.8%
 -8.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Arcus Biosciences Inc RCUS 10% Owner 2018-03-19 470,427 2018-03-19 0    Premium*  
            Immune Design Corp. IMDZ 10% Owner 2017-10-27 6,642,942 2017-10-27 0    Premium*  
            Constellation Pharmaceuticals Inc CNST 10% Owner 2021-02-17 2,584,957 2021-02-17 3,645,681    Premium*  
            Ngm Biopharmaceuticals Inc NGM Managing Partner, 10% ... 2020-09-02 18,052,932 2020-09-02 190,000    Premium*  
            Revolution Medicines, Inc. RVMD Managing Partner, 10% ... 2020-02-18 7,977,384 2020-02-18 0    Premium*  
            Surrozen Ord Shs SRZN 0 2024-04-04 326,992    Premium*  
* Premium Members only  

Records found :    57         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-04-08 4 B $16.00 $30,240,000 D/D 1,890,000 15,000 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-10-09 4 B $10.26 $181,848 D/D 17,724 17,724 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-10-10 4 B $10.50 $186,102 D/D 17,724 35,448 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-10-11 4 B $10.57 $187,343 D/D 17,724 53,172 2.45 -
CNST Constellation Pharmaceuti... 10% Owner   –       –       •   2018-07-23 4 A $0.00 $0 I/I 79,155 79,155 0 -
CNST Constellation Pharmaceuti... 10% Owner   –       –       •   2021-02-17 4 S $36.95 $369,503 I/I (10,000) 99,155 0 %
SRZN Surrozen Ord Shs   –       •       •   2024-04-04 4/A B $15.50 $2,999,994 I/I 193,548 326,992 0.01 -
SRZN Surrozen Ord Shs   –       •       •   2024-04-04 4 B $15.50 $2,999,994 I/I 193,548 332,885 0.01 -
RCUS Arcus Biosciences Inc 10% Owner   –       –       •   2018-03-19 4 A $0.00 $0 D/D 3,540,850 470,427 0 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2020-08-13 4 B $17.89 $355,922 D/D 19,895 1,637,579 2.45 %
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2020-08-14 4 B $17.49 $664,498 D/D 37,993 1,675,572 2.45 %
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2020-08-17 4 B $17.89 $114,943 D/D 6,425 1,681,997 2.45 %
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2020-08-21 4 B $17.97 $131,558 D/D 7,321 1,689,318 2.45 %
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2020-08-24 4 B $17.96 $197,991 D/D 11,024 1,700,342 2.45 %
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2020-08-25 4 B $18.00 $1,800 D/D 100 1,700,442 2.37 %
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2020-08-27 4 B $17.79 $646,827 D/D 36,359 1,736,801 2.45 %
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2020-08-28 4 B $17.89 $467,555 D/D 26,135 1,762,936 2.45 %
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2020-09-01 4 B $17.64 $643,754 D/D 36,494 1,799,430 2.45 %
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2020-09-02 4 B $17.67 $487,604 D/D 27,595 1,827,025 2.45 %
NGM Ngm Biopharmaceuticals In... 10% Owner   –       –       •   2019-04-08 3 IO $0.00 $0 D/D 0 1,890,000 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-05-07 4 B $14.10 $803,700 D/D 57,000 1,932,000 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-05-10 4 B $13.85 $248,234 D/D 17,923 1,949,923 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-05-20 4 B $13.50 $675,000 D/D 50,000 1,999,923 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-06-04 4 B $13.39 $168,764 D/D 12,600 2,012,523 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-06-06 4 B $13.40 $168,884 D/D 12,600 2,025,123 2.45 -

  57  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed